Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Epioxa’s commercial launch is progressing as payer access expands and Photrexa sunset continues. iDose and core MIGS businesses are growing, with a pipeline and new screening device supporting future expansion, as management targets rapid patient ramp-up.
Epioxa’s commercial launch is progressing as payer access expands and Photrexa has been sunset. iDose continues to grow with strong Medicare Advantage uptake, while the pipeline advances with multiple clinical milestones expected in the next 18 months.